Search

Your search keyword '"Lourenco MV"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Lourenco MV" Remove constraint Author: "Lourenco MV" Database MEDLINE Remove constraint Database: MEDLINE
41 results on '"Lourenco MV"'

Search Results

1. Defective regulation of the eIF2-eIF2B translational axis underlies depressive-like behavior in mice and correlates with major depressive disorder in humans.

2. The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease.

3. Effects of Gestational Exercise on Nociception, BDNF, and Irisin Levels in an Animal Model of ADHD.

4. Irisin limits amyloid-β buildup in Alzheimer's disease.

5. Cross-species comparative hippocampal transcriptomics in Alzheimer's disease.

6. Synaptic proteasome is inhibited in Alzheimer's disease models and associates with memory impairment in mice.

7. Emerging concepts towards a translational framework in Alzheimer's disease.

8. Association of the fibronectin type III domain-containing protein 5 rs1746661 single nucleotide polymorphism with reduced brain glucose metabolism in elderly humans.

9. The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasis.

10. EDITOR SPOTLIGHT: Interview with Brain Proteostasis Special Issue Guest Editor Mychael Lourenco.

11. Preface: Special issue "Brain Proteostasis in Health and Disease".

12. Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.

13. Promoting diversity and overcoming publication barriers in Latin American neuroscience and Alzheimer's disease research: A call to action.

14. Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression.

15. Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans.

16. Irisin stimulates protective signaling pathways in rat hippocampal neurons.

17. Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD.

18. Editorial: Honouring John Hardy - A true pioneer in research.

19. How does the skeletal muscle communicate with the brain in health and disease?

20. Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer's disease.

21. Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.

22. Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.

23. Amyloid-β oligomers in cellular models of Alzheimer's disease.

24. Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer's disease.

25. The Next 50 Years of Neuroscience.

26. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models.

27. Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.

28. Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches.

29. The malleable brain: plasticity of neural circuits and behavior - a review from students to students.

30. Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons.

31. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.

32. Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.

34. Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes.

35. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

36. Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease.

37. d-serine levels in Alzheimer's disease: implications for novel biomarker development.

38. How does brain insulin resistance develop in Alzheimer's disease?

39. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.

40. 2,4-Dinitrophenol induces neural differentiation of murine embryonic stem cells.

Catalog

Books, media, physical & digital resources